Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

USA - NASDAQ:QDEL - US2197981051 - Common Stock

26.17 USD
-0.14 (-0.53%)
Last: 10/14/2025, 8:11:01 PM
26.17 USD
0 (0%)
After Hours: 10/14/2025, 8:11:01 PM
Fundamental Rating

4

Taking everything into account, QDEL scores 4 out of 10 in our fundamental rating. QDEL was compared to 191 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of QDEL while its profitability can be described as average. QDEL scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

QDEL had positive earnings in the past year.
QDEL had a positive operating cash flow in the past year.
In multiple years QDEL reported negative net income over the last 5 years.
In the past 5 years QDEL always reported a positive cash flow from operatings.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -7.31%, QDEL is in the better half of the industry, outperforming 64.92% of the companies in the same industry.
QDEL has a Return On Equity of -16.70%. This is in the better half of the industry: QDEL outperforms 61.26% of its industry peers.
QDEL has a better Return On Invested Capital (1.72%) than 68.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 8.89%.
Industry RankSector Rank
ROA -7.31%
ROE -16.7%
ROIC 1.72%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

QDEL has a Operating Margin of 4.15%. This is in the better half of the industry: QDEL outperforms 69.11% of its industry peers.
QDEL's Operating Margin has declined in the last couple of years.
The Gross Margin of QDEL (47.29%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 4.15%
PM (TTM) N/A
GM 47.29%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QDEL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for QDEL has been increased compared to 5 years ago.
Compared to 1 year ago, QDEL has a worse debt to assets ratio.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.78, QDEL perfoms like the industry average, outperforming 48.17% of the companies in the same industry.
QDEL has a debt to FCF ratio of 200.49. This is a negative value and a sign of low solvency as QDEL would need 200.49 years to pay back of all of its debts.
The Debt to FCF ratio of QDEL (200.49) is better than 66.49% of its industry peers.
QDEL has a Debt/Equity ratio of 0.74. This is a neutral value indicating QDEL is somewhat dependend on debt financing.
QDEL has a worse Debt to Equity ratio (0.74) than 71.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 200.49
Altman-Z 0.78
ROIC/WACC0.24
WACC7.28%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.12 indicates that QDEL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, QDEL is doing worse than 85.34% of the companies in the same industry.
A Quick Ratio of 0.62 indicates that QDEL may have some problems paying its short term obligations.
QDEL's Quick ratio of 0.62 is on the low side compared to the rest of the industry. QDEL is outperformed by 90.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.62
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.10%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -3.28%.
Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%

3.2 Future

The Earnings Per Share is expected to grow by 24.45% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 1.95% on average over the next years.
EPS Next Y29.05%
EPS Next 2Y32.86%
EPS Next 3Y31.48%
EPS Next 5Y24.45%
Revenue Next Year-2.47%
Revenue Next 2Y0.19%
Revenue Next 3Y1.73%
Revenue Next 5Y1.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

QDEL is valuated reasonably with a Price/Earnings ratio of 11.18.
QDEL's Price/Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 90.58% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.49. QDEL is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 8.01, the valuation of QDEL can be described as very reasonable.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaply inside the industry as 97.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, QDEL is valued rather cheaply.
Industry RankSector Rank
PE 11.18
Fwd PE 8.01
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

93.72% of the companies in the same industry are more expensive than QDEL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QDEL indicates a somewhat cheap valuation: QDEL is cheaper than 69.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 136.69
EV/EBITDA 7.64
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 31.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y32.86%
EPS Next 3Y31.48%

0

5. Dividend

5.1 Amount

No dividends for QDEL!.
Industry RankSector Rank
Dividend Yield N/A

QUIDELORTHO CORP

NASDAQ:QDEL (10/14/2025, 8:11:01 PM)

After market: 26.17 0 (0%)

26.17

-0.14 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners117.77%
Inst Owner Change-1.09%
Ins Owners0.58%
Ins Owner Change2.28%
Market Cap1.78B
Analysts77.14
Price Target42.16 (61.1%)
Short Float %12.2%
Short Ratio5.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)357.74%
Min EPS beat(2)23.78%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)220.56%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)120.88%
EPS beat(12)10
Avg EPS beat(12)95.2%
EPS beat(16)13
Avg EPS beat(16)76.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)-1.51%
Revenue beat(4)1
Avg Revenue beat(4)1.81%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)11.02%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)8
Avg Revenue beat(12)2.33%
Revenue beat(16)11
Avg Revenue beat(16)4.56%
PT rev (1m)-6.06%
PT rev (3m)-17.8%
EPS NQ rev (1m)-0.75%
EPS NQ rev (3m)-31.03%
EPS NY rev (1m)-1.73%
EPS NY rev (3m)-2.57%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)-4.24%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 11.18
Fwd PE 8.01
P/S 0.65
P/FCF 136.69
P/OCF 8.87
P/B 0.64
P/tB N/A
EV/EBITDA 7.64
EPS(TTM)2.34
EY8.94%
EPS(NY)3.27
Fwd EY12.48%
FCF(TTM)0.19
FCFY0.73%
OCF(TTM)2.95
OCFY11.28%
SpS40.38
BVpS41.13
TBVpS-8.53
PEG (NY)0.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.31%
ROE -16.7%
ROCE 2.17%
ROIC 1.72%
ROICexc 1.77%
ROICexgc 5.25%
OM 4.15%
PM (TTM) N/A
GM 47.29%
FCFM 0.47%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 200.49
Debt/EBITDA 3.74
Cap/Depr 42.61%
Cap/Sales 6.84%
Interest Coverage 250
Cash Conversion 36.19%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.62
Altman-Z 0.78
F-Score5
WACC7.28%
ROIC/WACC0.24
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.1%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%271.43%
EPS Next Y29.05%
EPS Next 2Y32.86%
EPS Next 3Y31.48%
EPS Next 5Y24.45%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.63%
Revenue Next Year-2.47%
Revenue Next 2Y0.19%
Revenue Next 3Y1.73%
Revenue Next 5Y1.95%
EBIT growth 1Y8.79%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year937.44%
EBIT Next 3Y134.39%
EBIT Next 5Y88.82%
FCF growth 1Y-88.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.98%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%